Craif and National Cancer Center Hospital East Signed a New Joint Study Agreement
Craif and Tokyo Medical University Signed a New Joint Study Agreement
Craif and Cancer Institute Hospital of JFCR Signed a New Joint Study Agreement for Breast Cancer
Craif and The Jikei University School of Medicine Signed a New Joint Study Agreement
Craif and Thoracic Surgery Department at Higashiosaka City Medical Center Started a New Joint Study
Craif’s Urine Cancer Testing Initiative Was Featured in Nature Online Edition
Craif Presented a Study Result of “Urinary miRNA as a Biomarker for Early Stage Ovarian Cancer Detection” at the 80th Annual Meeting of the Japanese Cancer Association
Dr. Yasui, Co-Founder and Nanodevice Director of Craif, Gave a Symposium Lecture at the 41st Annual Meeting of the Japanese Society for Molecular Tumor Marker Research
Craif and Kumagaya General Hospital Started a New Joint Study
Craif and Chiba University Presented the Study Result of Early Detection of Ovarian Cancer Using Urine at the “ESMO Congress 2021”